Tvardi Therapeutics (TVRD) Revenue: 2012-2016
Historic Revenue for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2016 value amounting to $86,000.
- Tvardi Therapeutics' Revenue rose 12914.29% to $911,000 in Q1 2017 from the same period last year, while for Mar 2017 it was $3.4 million, marking a year-over-year decrease of 9.79%. This contributed to the annual value of $86,000 for FY2016, which is 97.74% down from last year.
- Per Tvardi Therapeutics' latest filing, its Revenue stood at $86,000 for FY2016, which was down 97.74% from $3.8 million recorded in FY2015.
- Over the past 5 years, Tvardi Therapeutics' Revenue peaked at $12.0 million during FY2013, and registered a low of $86,000 during FY2016.
- Moreover, its 3-year median value for Revenue was $3.2 million (2014), whereas its average is $2.4 million.
- In the last 5 years, Tvardi Therapeutics' Revenue soared by 905.38% in 2013 and then tumbled by 97.74% in 2016.
- Over the past 5 years, Tvardi Therapeutics' Revenue (Yearly) stood at $1.2 million in 2012, then surged by 905.38% to $12.0 million in 2013, then slumped by 73.45% to $3.2 million in 2014, then climbed by 19.70% to $3.8 million in 2015, then tumbled by 97.74% to $86,000 in 2016.